HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen.

Abstract
The tumor-associated glycoprotein 72 (TAG-72) is a membrane mucin whose over-expression is correlated with advanced tumor stage and increased invasion and metastasis. In this study, we identified a panel of four nanobodies, single variable domains of dromedary heavy-chain antibodies that specifically recognize the TAG-72 antigen. All selected nanobodies were shown to selectively bind to this cancer-related molecule with low-nanomolar affinities and do not cross-react with other antigens, such as MUC1 or HER2. Furthermore, they can detect TAG-72 in concentrations as low as 5 U/ml which is valuable in sensitive detection of this molecule in cancerous patients. Cell ELISA experiments proved their ability for binding to the native target antigen on TAG-72 expressing cells while not showing any reactivity to HT-29 cells, a TAG-72-negative cell line. Using competition studies, we found that each nanobody recognizes a distinct epitope on the TAG-72 antigen that is different from the one recognized by the mouse anti-TAG-72 antibody, CC49. Considering their high specificity, reduced immunogenicity and multi-targeting behavior, these oligoclonal nanobodies represent a promising tool to target TAG-72 over-expressing tumor cells.
AuthorsZahra Sharifzadeh, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar, Davoud Ahmadvand, Fereidoun Mahboudi, Fatemeh Rahimi Jamnani, Seyed Hamid Aghaee Bakhtiari
JournalMolecular biotechnology (Mol Biotechnol) Vol. 54 Issue 2 Pg. 590-601 (Jun 2013) ISSN: 1559-0305 [Electronic] United States
PMID23015323 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Antigens, Neoplasm
  • Epitopes
  • Glycoproteins
  • Mucin-1
  • Single-Domain Antibodies
  • tumor-associated antigen 72
  • Receptor, ErbB-2
Topics
  • Animals
  • Antibodies (immunology)
  • Antibody Formation
  • Antibody Specificity (immunology)
  • Antigens, Neoplasm (immunology)
  • Camelus (immunology)
  • Cell Line, Tumor
  • Cell Surface Display Techniques (methods)
  • Cross Reactions (immunology)
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Epitopes (immunology)
  • Glycoproteins (immunology)
  • HT29 Cells
  • Humans
  • Male
  • Mice
  • Mucin-1 (immunology)
  • Receptor, ErbB-2 (immunology)
  • Single-Domain Antibodies (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: